Ardea Biosciences, Inc. RDEA today reported recent accomplishments and announced fourth quarter 2010 financial results.
Revenues totaled $17.3 million and $27.4 million for the three and twelve months ended December 31, 2010, respectively.
Net loss for the three and twelve months ended December 31, 2010 was $0.6 million and $41.6 million, or $0.03 per share and $1.91 per share, respectively, compared to a net loss for the same periods in 2009 of $6.3 million and $30.9 million, or $0.34 per share and $1.70 per share, respectively.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
